The SGC operates from three academic institutions - the University of Toronto, the University of Oxford and the State University of Campinas (Unicamp) in Brazil - ensuring the SGC labs a remarkable level of engagement and exchange with their respective local academic communities. In these three SGC labs, there are in excess of 230 scientists, visitors, collaborators and support personnel at any time working on several research areas.
All three labs employ, develop and exchange high-throughput structural biology, medicinal chemistry and assay development expertise and protocols and are unified through a common informatics platform, ensuring seamless flow of information and integration. In parallel, built within this integrated platform, both SGC sites conduct several, non-overlapping scientific programmes aimed at exploring pioneer targets and biology.
The SGC Oxford laboratory is part of the Nuffield Department of Clinical Medicine, at the University of Oxford. The Chief Scientist at SGC Oxford is Prof. Chas Bountra, who joined the SGC in 2007, bringing more than 20 years of leadership experience in pharmaceutical industry.
The SGC Karolinska laboratory is housed within the Department of Medicine at Karolinska Institutet, and located at the Centre for Molecular Medicine. The lab was opened in 2015 and is directed by Prof. Michael Sundström, previously Chief Scientist for SGC Oxford (2003 – 2007). Work at SGC Karolinska is focused on patient-derived cell assays for auto-immune diseases as well as the production of high quality antibodies and biological probes.